Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 15 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

15 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
May 16, 2023 MDXG S 10,365 $5.95 $61,672 317,803 Direct -3.16% Disposed -22.9% (price as of 2026-10-02)
May 15, 2023 MDXG S 3,607 $6.15 $22,183 328,168 Direct -1.09% Disposed -25.4% (price as of 2026-10-02)
May 10, 2023 MDXG S 5,869 $5.93 $34,803 331,775 Direct -1.74% Disposed -22.6% (price as of 2026-10-02)
May 4, 2023 MDXG S 51,756 $5.34 $276,377 337,644 Direct -13.29% Disposed -14.0% (price as of 2026-10-02)
April 25, 2023 MDXG S 5,987 $3.74 $22,391 389,400 Direct -1.51% Disposed 22.7% (price as of 2026-10-02)
April 11, 2023 MDXG S 5,996 $3.31 $19,847 395,387 Direct -1.49% Disposed 38.7% (price as of 2026-10-02)
March 7, 2023 MDXG S 12,355 $4.24 $52,385 266,318 Direct -4.43% Disposed 8.3% (price as of 2026-10-02)
Sept. 13, 2022 MDXG S 8,329 $3.46 $28,818 278,673 Direct -2.90% Disposed 32.7% (price as of 2026-10-02)
Sept. 12, 2022 MDXG S 19,000 $3.44 $65,360 287,002 Direct -6.21% Disposed 33.4% (price as of 2026-10-02)
Aug. 12, 2022 MDXG S 8,503 $4.04 $34,352 306,002 Direct -2.70% Disposed 13.6% (price as of 2026-10-02)
Aug. 4, 2022 MDXG S 19,500 $3.62 $70,590 314,505 Direct -5.84% Disposed 26.8% (price as of 2026-10-02)
June 28, 2022 MDXG S 14,600 $3.47 $50,662 334,005 Direct -4.19% Disposed 32.3% (price as of 2026-10-02)
March 8, 2022 MDXG S 11,672 $4.86 $56,726 170,034 Direct -6.42% Disposed -5.6% (price as of 2026-10-02)
Aug. 16, 2021 MDXG S 9,362 $11.85 $110,940 181,706 Direct -4.90% Disposed -61.3% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
July 15, 2026 PYPD Stock option (right to buy) Ordinary Shares (9,132) $4.46 July 15, 2036 9,132 Acquired
March 31, 2017 AGEN Stock Option, Right to Buy Common Stock (100,000) $3.77 March 31, 2027 100,000 Acquired
June 14, 2016 AGEN Stock Option, right to buy Common Stock (250,000) $4.16 March 31, 2026 250,000 Acquired
June 14, 2016 AGEN Restricted Stock Unit Common Stock · March 31, 2019 34,000 Acquired
July 6, 2015 AGEN Stock Option, right to buy Commmon Stock (18,750) $5.04 Feb. 12, 2025 18,750 Acquired
Feb. 12, 2015 AGEN Stock Option, Right to Buy Common Stock $5.04 Feb. 12, 2025 87,500 Acquired
Feb. 14, 2014 AGEN Stock Option, Right to Buy Common Stock (200,000) $3.00 Feb. 14, 2024 200,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 7 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
April 6, 2026 PYPD Stock option (right to buy)→ Ordinary Shares · Direct
April 6, 2026 PYPD Stock option (right to buy)→ Ordinary Shares · Direct
April 6, 2026 PYPD Stock option (right to buy)→ Ordinary Shares · Direct
April 6, 2026 PYPD Stock option (right to buy)→ Ordinary Shares · Direct
April 6, 2026 PYPD Stock option (right to buy)→ Ordinary Shares · Direct
April 6, 2026 PYPD Stock option (right to buy)→ Ordinary Shares · Direct
Jan. 15, 2014 AGEN Stock Option, right to buy→ Common Stock (150,000) 150,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2017 $122,596 · · · · · $600,406 $1,043,014
2016 $411,635 $200,000 · · · · $167,133 $1,559,106
2015 $373,654 $249,600 · · · · $101,559 $1,137,957

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.